Gelteq Limited (GELS) - Net earnings per share (EPS TTM)

Symbol and logo of brand Gelteq (GELS)

The 12-month rolling earnings per share history on the GURU.Markets chart correlates with Gelteq Limited (GELS) R&D projects aimed at improving the bioavailability of nutraceuticals through gel formulas. Patent monetization and licensing deals allow the company to avoid price competition. The -0.45 indicator expresses the current value of the metric, while the business's financial success depends on regulatory approval of drugs rather than GDP dynamics.

GELS (gelteq.com) Earnings per share for the last 12 months history from 10/30/2024 to 11/15/2026

Comprehensive metric breakdowns and analytics for Gelteq Limited Inc (GELS)

- share price and expert price forecast:
Stock Quotes Gelteq Limited|GELS - Forecast Levels Chart
- market capitalization indicators:
Market Capitalization Gelteq Limited|GELS - Total Enterprise Value
- business book valuation details:
Book Value per Share Gelteq|GELS - Accounting Capitalization|Market Cap to Net Assets Ratio gelteq.com|GELS - Aggregate Asset Value
- debt and liquidity details:
Debt to Equity Gelteq Limited|GELS - Long-Term Liabilities to Equity|Short-Term Debt to Capital Gelteq|GELS - Aggregate Debt Obligations|Debts to Book Capitalization Gelteq Ltd|GELS - Company Long-Term Debts|Company Short-Term Debt Gelteq|Quick Liquidity gelteq.com
- net income and valuation multiples indicators:
GELS - Net Income|Projected Future Earnings Gelteq Limited|GELS - P/E Multiple|Forward P/E Multiple gelteq.com|GELS - Price to Net Income Growth Ratio|EV/EBITDA Multiple Gelteq Limited|GELS - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Gelteq|GELS - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months gelteq.com|GELS - Net earnings per one share growth for the current year|Earnings growth forecast for next year Gelteq Limited
- sales volume and revenue information:
GELS - Company Total Revenue|Company Projected Revenue gelteq.com|GELS - Price-to-Revenue Multiple|Forward Price-to-Revenue Multiple GELS|GELS - Revenue Dynamics YoY (Last Twelve Months)
General company analysis:Gelteq (GELS)
Mass-produced product of Gelteq Ltd

Net income per share serves as a key indicator of return on equity in fundamental analysis. The trend in net income per share over the last 12 months demonstrates the actual efficiency of profit generation per share of ownership. This metric is calculated by dividing the total annual net income by the total number of outstanding shares. For Gelteq Limited (GELS), this figure reflects the commercial success of implementing innovative gel-based drug delivery. The growth of this indicator confirms the scaling demand for alternative forms of medication administration.

Competitors of Gelteq Limited (GELS)

VRTX: Net earnings per share for the last 12 months|Earnings per one share for the last 12 months ALNY|INSM: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months United Therapeutics Corp. (UTHR)|BMRN (BioMarin) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BBIO (BridgeBio)|Earnings per share for the last twelve months bgm.ltd (BGM)|COGT (Cogent Biosciences Inc) - Earnings per share for the trailing year|Earnings per share for the last twelve months Xeris Biopharma Holdings XERS|KROS (Keros Pharma) - Earnings per one share for the last 12 months|Arcturus Therapeutics - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ETON (Eton Pharmaceuticals)|KMDA: Net earnings per share (EPS TTM)|Fulcrum Therapeutics Inc (FULC) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months abeonatherapeutics.com|MREO: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PLX|Net earnings per share for the last 12 months Pliant Therapeutics, Inc. PLRX|Net earnings per share (EPS TTM) APLT (Applied Therapeutics Inc.)|Net earnings per share (EPS TTM) Rein Therapeutics Inc. RNTX|Aytu BioPharma, Inc. - Net earnings per share (EPS TTM)|chemomab.com (CMMB) - Net earnings per share for the last 12 months|SRx Health (SRXH) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Polyrizon Ltd. (PLRZ)|Net earnings per share for the last 12 months AEZS|Net earnings per share for the last 12 months Cyclo Therapeutics Inc. (CYTH)|Net earnings per share for the last 12 months INZY (inozyme.com)|RPHM - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) CSCI (cosciensbio.com)